• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌二醇和孕酮治疗对女性脂质及脂蛋白的影响。

Effects on lipids and lipoproteins in women treated with oestradiol and progesterone.

作者信息

Darj E, Crona N, Nilsson S

机构信息

Department of Obstetrics and Gynaecology, Falun Hospital, Sweden.

出版信息

Maturitas. 1992 Dec;15(3):209-15. doi: 10.1016/0378-5122(92)90204-h.

DOI:10.1016/0378-5122(92)90204-h
PMID:1465034
Abstract

Thirty women with climacteric symptoms were treated for 4 months with 2 mg 17 beta-oestradiol and different doses of progesterone (50, 100 or 200 mg). The concentrations of total and free cholesterol, phospholipids, triglycerides (TG), apoprotein A1 and apoprotein B were determined in high-density lipoprotein (HDL), low-density lipoprotein (LDL) and very-low-density lipoprotein (VLDL) fractions and in serum. HDL levels increased and LDL levels decreased, while TG levels in VLDL remained unchanged, which indicates that the lipoprotein pattern is oestrogen-induced and that progesterone exerts little or no influence.

摘要

30名有更年期症状的女性接受了为期4个月的治疗,使用2毫克17β - 雌二醇和不同剂量的孕酮(50、100或200毫克)。测定了高密度脂蛋白(HDL)、低密度脂蛋白(LDL)和极低密度脂蛋白(VLDL)组分以及血清中总胆固醇、游离胆固醇、磷脂、甘油三酯(TG)、载脂蛋白A1和载脂蛋白B的浓度。HDL水平升高,LDL水平降低,而VLDL中的TG水平保持不变,这表明脂蛋白模式是由雌激素诱导的,孕酮几乎没有影响。

相似文献

1
Effects on lipids and lipoproteins in women treated with oestradiol and progesterone.雌二醇和孕酮治疗对女性脂质及脂蛋白的影响。
Maturitas. 1992 Dec;15(3):209-15. doi: 10.1016/0378-5122(92)90204-h.
2
Lipid metabolic studies in oophorectomized women: effects induced by two different estrogens on serum lipids and lipoproteins.卵巢切除术后女性的脂质代谢研究:两种不同雌激素对血清脂质和脂蛋白的影响。
Gynecol Obstet Invest. 1980;11(3):161-9. doi: 10.1159/000299833.
3
Long-term influence of different postmenopausal hormone replacement regimens on serum lipids and lipoprotein(a): a randomised study.不同绝经后激素替代方案对血脂和脂蛋白(a)的长期影响:一项随机研究。
Br J Obstet Gynaecol. 1997 Jun;104(6):708-17. doi: 10.1111/j.1471-0528.1997.tb11982.x.
4
Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters.两种含炔雌醇和孕二烯酮或诺孕酯的口服避孕药对不同脂质和脂蛋白参数的影响。
Contraception. 1998 Aug;58(2):83-91. doi: 10.1016/s0010-7824(98)00074-2.
5
Lipoproteins during oral and cutaneous administration of oestradiol-17 beta to menopausal women.绝经后女性经口服和皮肤给药雌二醇-17β期间的脂蛋白
Acta Endocrinol (Copenh). 1982 Dec;101(4):597-602. doi: 10.1530/acta.0.1010597.
6
A randomized crossover comparison of two low-dose contraceptives: effects on serum lipids and lipoproteins.两种低剂量避孕药的随机交叉比较:对血清脂质和脂蛋白的影响。
Am J Obstet Gynecol. 1985 Oct 1;153(3):287-93. doi: 10.1016/s0002-9378(85)80114-9.
7
Effect of estrogen-progestin replacement therapy on plasma lipids and lipoproteins in postmenopausal women.
Endocr Res. 2000 May;26(2):263-73. doi: 10.3109/07435800009066166.
8
Hormone replacement therapy and lipid-lipoprotein concentrations.激素替代疗法与脂质-脂蛋白浓度
Eur J Obstet Gynecol Reprod Biol. 1999 Jul;85(1):31-41. doi: 10.1016/s0301-2115(98)00279-6.
9
A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.一项关于两种三相口服避孕药对血脂影响的两年临床研究。
Int J Fertil Menopausal Stud. 1994 Sep-Oct;39(5):283-91.
10
A comparison of the effects of ethinyl estradiol and estradiol valerate on serum and lipoprotein lipids.
Maturitas. 1988 Dec;10(4):343-52. doi: 10.1016/0378-5122(88)90069-2.

引用本文的文献

1
Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease.激素替代疗法:II. 对其在预防绝经后骨质疏松症和缺血性心脏病中作用的药物经济学评估。
Pharmacoeconomics. 1994 Jun;5(6):513-54. doi: 10.2165/00019053-199405060-00007.
2
Impact of hormone replacement therapy on postprandial lipoproteins and lipoprotein(a) in normolipidemic postmenopausal women.
Clin Investig. 1994 Jul;72(7):502-7. doi: 10.1007/BF00207478.